On-site-SCT: On-site Supportive Communication Training in Doctor-Patient Communication

Sponsor
Vejle Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05842083
Collaborator
Zealand University Hospital (Other), Aalborg University Hospital (Other)
80
2
14

Study Details

Study Description

Brief Summary

The goal of this randomized, controlled clinical trial is to test a new concept for communication skills training (on-site supportive communication training (on-site SCT) in cancer care. The study aims to determine the impact of on-site SCT on patients' rating of oncologists' communication abilities.

Oncologists participating in the study will be randomized to the intervention or control group. In the intervention group each doctor will have a total of three intervention days at intervals of 3-4 weeks. On an intervention day, a psychologist will sit in and observe doctor-patient consultations. After the first patient consultations, 30 minutes are allocated for feedback to the doctor by the psychologist. After the last consultation of the day, 60 minutes are allocated for thorough feedback and establishment of learning goals to focus on until the next intervention day. Doctor's in the control group will conduct communication as usual.

Reseachers will compare the control and intervention groups to see if patients' rating of doctors' interpersonal and communication skills increase when they participate in on-site SCT. The 15-item Communication Assessment Tool (CAT) will be used.

It will also be investigated whether on-site SCT will increase the doctors' rating of themselves in relation to communication efficacy and job-satisfaction and decrease their experience of burnout.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: On-site supportive communication training
N/A

Detailed Description

BACKGROUND Oncologists carry a heavy responsibility when delivering information to cancer patients and helping them navigate through decisions about life-altering treatments, survivorship, and end-of-life care. Comprehensive person-centered psychosocial cancer care should be adapted to the individual patient, which is obviously a challenging task (Dilworth, et al. 2014). Individualized and empathic communication, on the other hand, is of substantial importance to patient satisfaction, adherence to treatment, empowerment, and the ability to navigate in the disease trajectory (Gattellari, et al. 2001; Stewart 1995; Vogel, et al. 2009).

The quality of the communication in medical care has been shown to influence health outcomes, as it increases the risk of unnecessary treatment and is linked to insufficient pain relief and higher anxiety levels (Thorne, et al. 2005). Therefore, considerable effort has been dedicated to interventions that may improve the communication skills of healthcare professionals involved in cancer care (Moore, et al. 2018). The primary purpose has been to improve the quality of the doctor-patient-communication including the doctors' interpersonal skills.

Previous papers have suggested direct feedback on observed situations as an ideal method for improving communication skills (Anderson 2012; Burgess, et al. 2020), but to the best of our knowledge, no randomized clinical trials have used patient feedback during on-site training. Studies on communication skills training courses with recorded consultations/role-play have shown significant effect on key communication skills (Fallowfield, et al. 2002) and increased self-efficacy (Ammentorp, et al. 2007). Two studies have demonstrated long-term maintenance of acquired skills (Finset, et al. 2003; Gulbrandsen, et al. 2013). Until now, no effect on burnout has been demonstrated (Bragard, et al. 2010a; Bragard, et al. 2010b).

Clinical supervision and training aims to develop clinical practice and provide a protected space to allow an educational and reflective process to occur. Although there is still no empirical definition of the term supervision (Milne 2007), in 2004 Bernard and Goodyear defined it as "an intervention provided by a more senior member of a profession to a more junior member or members of that same profession"(Bernard 2004). On this premise, psychologists cannot formally supervise doctors and other terms must be used. In this project we therefore use the term "on-site supportive communication training" (on-site SCT) when referring to the intervention given by the psychologists.

Psychologists have a long tradition of working with communication, creating a reflective learning space, making observations and providing feedback. It is therefore highly relevant to use dedicated psychologists to investigate the effect of on-site SCT on the doctors' communication and on their experienced level of self-efficacy, satisfaction and burn-out.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Oncologists will be randomized between the intervention and usual practice.Oncologists will be randomized between the intervention and usual practice.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
On-site Supportive Communication Training in Doctor-Patient Communication: A Randomized, Controlled Trial
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention

Each oncologist will have a total of three intervention days with a psychologist sitting in and observing the doctor-patient consultations and subsequently providing feedback.

Behavioral: On-site supportive communication training
On-site supportive communication training

No Intervention: Control

Oncologists in the control group will conduct consultations as usual.

Outcome Measures

Primary Outcome Measures

  1. Difference in rate of "Excellent" scores on the Communication Assessment Tool between the intervention and the control group. [6 months]

    Patients rate the doctor's communcation skills right after the consultation.

Secondary Outcome Measures

  1. Change in oncologists' rating of own communication efficacy according to the "Self-efficacy in Health Communication" tool from before to after on-site communication training. [6 months]

    The Self-efficacy in Health Communication tool consists of 12 questions eliciting the healthcare professionals' perceived self-efficacy in communication with patients using a 10-point scale from "very uncertain" (1) to "very certain" (10).

  2. Change in oncologists' rating of burnout according to part 2 and 3 of the Copenhagen Burnout Inventory tool from before to after on-site communication training. [6 months]

    The reply options in relation to burnout range from 1 (To a very high degree/always), to 5 (To a very low degree/never-almost never)

  3. Change in oncologists' rating of job satisfaction from before to after on-site communication training. [6 months]

    Job satisfaction is measured in Denmark every other year at the nation-wide employee satisfaction survey, which survey offers a large amount of comparable data. Five items directly concerning job satisfaction will be extracted from the survey.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Medical doctors

  • Employed at the Department of Oncology at Vejle Hospital, University Hospital of Southern Denmark, Aalborg University Hospital, or Zealand University Hospital, Roskilde/Næstved.

  • Work in the outpatient clinics at the participating departments

Exclusion Criteria:
  • Doctors whose employment contracts will expire during the study and who do not plan to continue working at the department.

  • Doctors who are not willing to sign the informed consent form.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Vejle Hospital
  • Zealand University Hospital
  • Aalborg University Hospital

Investigators

  • Principal Investigator: Kerstin Kiis Antonsen, MD, University Hospital of Southern Denmark - Vejle Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Vejle Hospital
ClinicalTrials.gov Identifier:
NCT05842083
Other Study ID Numbers:
  • On-site SCT
First Posted:
May 3, 2023
Last Update Posted:
May 3, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 3, 2023